PAN-PROMISE to Detect Post-ERCP Pancreatitis Symptoms (PAN-PROMISE)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The aim of this study is to use a validated patient-reported outcome measure to evaluate how many patients have symptoms of pancreatitis after ERCP and how it correlates with their quality of life and productivity.
Condition or disease
Post-ERCP Acute Pancreatitis
This project will measure the impact of a recently validated patient-reported outcome measure for acute pancreatitis, PAN-PROMISE, to detect post-ERCP pancreatitis symptoms and capture its morbidity. We will compare the change of PAN-PROMISE before and after ERCP to the current standard diagnostic criteria for post-ERCP pancreatitis, the Cotton Consensus Criteria. The main limitations of the Cotton-Consensus Criteria are that it fails to capture outpatient or ambulatory morbidity, uses length of stay to define the severity of pancreatitis without accounting for local or systemic complications for pancreatitis, and it has limited sensitivity in patients with chronic symptoms such as patients with chronic pancreatitis or pancreatic adenocarcinoma. These limitations have impeded the evaluation of potential therapies to prevent post-ERCP pancreatitis. PAN-PROMISE will help capture and quantitate the morbidity related to post-ERCP pancreatitis and thus will enhance our ability to optimize outcomes following ERCP.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
We are enrolling patients who are undergoing ERCP at our two centers.
Patients undergoing ERCP
Age >= 18 years old
Intact major papilla
Unwillingness or inability to consent for the study
Age < 18 years
Standard contraindications to ERCP
Prior hepaticojejunostomy in a patient undergoing ERCP for a bile duct indication
Prior pancreaticojejunostomy in a patient undergoing ERCP for a pancreatic duct indication
Low probability of completing the follow-up
Acute pancreatitis (by the Revised Atlanta criteria) in the seven days prior to ERCP.
Patients who do not answer at least 80% of the questions on the baseline and 48-hour follow-up survey.
Patients who could not be contacted via a telephone call to assess for post-ERCP complications at 48-72 hours.
Patients who speak a language other than English, Spanish, Bulgarian, Mandarin, English, French, German, Greek, Hungarian, Italian, Korean, Polish, Portuguese, Romanian, Russian, Turkish, Ukrainian, or Hindi (as the PAN-PROMISE has only been translated and validated in these languages.